For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Gen9, Inc.

USPTO Granted Patents = 43

CIPO Patents = 7

EPO Patents = 22

Trademarks = 1

Forward Citations = 1,097

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Joseph M Jacobson (27 out of 139 patents)

Michael E Hudson (13 out of 14 patents)

Daniel Schindler (12 out of 13 patents)

4. Larry Li-Yang Chu (11 out of 11 patents)

5. Li-yun A Kung (7 out of 8 patents)

6. Senthil Ramu (7 out of 7 patents)

7. Andrew V Oleinikov (6 out of 10 patents)

8. Scott S Lawton (5 out of 6 patents)

9. Ishtiaq E Saaem (4 out of 4 patents)

10. Martin J Goldberg (4 out of 55 patents)

11. George M Church (3 out of 191 patents)

12. Andrew Wilson (3 out of 11 patents)

13. Mark A Fauci (3 out of 5 patents)

14. Giles F Hall (2 out of 2 patents)

15. Li-Yun A Kung (2 out of 2 patents)

Core Competencies:

Nucleic Acid Assembly

High Throughput Sequencing

Nucleic Acids Synthesis

Oligonucleotides Synthesis

Multiplex Nucleic Acids Synthesis

Polynucleotide Synthesis

Protein Arrays

Microarray Synthesis

Gene-Length Polynucleotides

Microfluidic Devices

DNA Error Reduction

Enzyme Catalysis

43 patents: Sort by Forward Citations

1. 12241057 - Methods for nucleic acid assembly and high throughput sequencing (2025-03-04),

2. 11845054 - Methods and devices for nucleic acids synthesis (2023-12-19),

3. 11702662 - Compositions and methods for high fidelity assembly of nucleic acids (2023-07-18),

4. 11242523 - Compositions, methods and apparatus for oligonucleotides synthesis (2022-02-08),

5. 11130948 - Compositions and methods for multiplex nucleic acids synthesis (2021-09-28),

6. 11084014 - Methods and devices for nucleic acids synthesis (2021-08-10),

7. 11072789 - Methods for nucleic acid assembly and high throughput sequencing (2021-07-27),

8. 11071963 - Assembly of high fidelity polynucleotides (2021-07-27),

9. 11015191 - Methods and devices for high fidelity polynucleotide synthesis (2021-05-25),

10. 10982208 - Protein arrays and methods of using and making the same (2021-04-20),

11. 10927369 - Methods for sorting nucleic acids and multiplexed preparative in vitro cloning (2021-02-23),

12. 10829759 - Methods and apparatuses for chip-based DNA error reduction (2020-11-10),

13. 10774325 - Microarray synthesis and assembly of gene-length polynucleotides (2020-09-15),

14. 10640764 - Microarray synthesis and assembly of gene-length polynucleotides (2020-05-05),

15. 10457935 - Protein arrays and methods of using and making the same (2019-10-29),

Gen9, Inc. is a synthetic biology company that leverages advanced technologies to design and manufacture high-quality DNA constructs for a wide range of applications. With their proprietary BioFab® platform, Gen9 offers a scalable and cost-effective solution for the synthesis of gene-length DNA fragments. Their services empower researchers, biotechnology companies, and pharmaceutical companies to accelerate their genomics research and development initiatives. Gen9 is dedicated to driving the adoption of synthetic biology and enabling breakthroughs in healthcare, agriculture, and industrial applications.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

43 Patents

#58 in Boston, MA

#452 in Massachusetts

#7,821 in US

#15,577 in the World

Boston, MA, United States of America

Gen9, Inc.

Forward Citations = 1,097

26 inventors:

Joseph M Jacobson (27 out of 139 patents)

Michael E Hudson (13 out of 14 patents)

Daniel Schindler (12 out of 13 patents)

4. Larry Li-Yang Chu (11 out of 11 patents)

5. Li-yun A Kung (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…